Avidity Partners Management LP Pacific Biosciences Of California, Inc. Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $2.38 Million - $6.47 Million	675,000 New	675,000 $2.53 Million
Q3 2023 Nov 14, 2023	SELL	$8.23 - $13.93 $27.2 Million - $46 Million	-3,303,106 Reduced 76.15%	1,034,294 $8.64 Million
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $5.23 Million - $7.37 Million	524,800 Added 13.76%	4,337,400 $57.7 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $30.3 Million - $45.8 Million	3,812,600 New	3,812,600 $44.1 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.